Immunohistochemistry in Lung Cancers
Publish place: The first international conference and the 3rd International Congress on Lung Cancer and Pulmonary Intervention
Publish Year: 1397
Type: Conference paper
Language: English
View: 520
این Paper فقط به صورت چکیده توسط دبیرخانه ارسال شده است و فایل کامل قابل دریافت نیست. برای یافتن Papers دارای فایل کامل، از بخش [جستجوی مقالات فارسی] اقدام فرمایید.
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- I'm the author of the paper
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
Export:
Document National Code:
LCPIMED03_011
Index date: 27 October 2018
Immunohistochemistry in Lung Cancers abstract
Immunohistochemistry plays a critical role in the classification of tumors into subtypes andfor assessing biomarkers for accurate therapeutic decision. Immunohistochemistry is a widelyavailable technique that is less challenging and can provide clinically meaningful results quicklyand cost-efficiently in comparison with other techniques.Pathologists are required to classify lung cancer into specific subtypes and assess biomarkersrelevant to molecular-targeted therapies.This lecture summarizes the hot topics of immunohistochemistry in lung cancer, including:1- Adenocarcinoma versus squamous cell carcinoma2- Neuroendocrine markers3- Lung carcinoma versus malignant mesothelioma4- Metastatic carcinoma versus primary lung carcinoma5- ALK, ROS1, EGFR and PD-L1Major pitfalls in evaluating immunohistochemical results are also described.
Immunohistochemistry in Lung Cancers authors
Mitra Heydarpour
M.D, Associate Professor of Pathology Isfahan University of Medical Sciences, Isfahan, Iran